Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Diabetes
Biotech
Amgen's ph. 3 MariTide studies will ramp up dosing to quell nausea
The company noted high rates of discontinuation due to gastrointestinal events, such as vomiting, in fixed-dose arms of its phase 2 trial.
Zoey Becker
Jun 24, 2025 9:59am
Abbott lines up diabetes collabs for its glucose-ketone sensor
Jun 20, 2025 11:41am
Medtronic adopts familiar name for its diabetes spinout: MiniMed
Jun 12, 2025 10:30am
Medtronic to spin out diabetes division as $2.8B company
May 21, 2025 10:40am
Roche to spend $550M building Indianapolis HQ into CGM hub
May 13, 2025 12:00pm
Biomea cuts staff, drops leukemia asset in metabolic shift
May 5, 2025 6:59pm
